Keyword Connections

imatinib

Journals

13

1 Journal of pharmaceutical and biomedical analysis

2 British journal of clinical pharmacology

3 Cureus

4 European journal of cancer (Oxford, England : 1990)

5 Journal of medical case reports

6 clinical lymphoma, myeloma & leukemia

7 hospitals

8 Therapeutic advances in hematology

9 Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

10 problemy radiatsiinoi medytsyny ta radiobiolohii

11 journal of the optical society of america

12 eurasian journal of medicine and oncology

13 Pharmacogenomics

Research Groups

0

No Research Group Connected

Bibliographies

18

1 The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.

2 Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.

3 Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.

4 Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report.

5 Assessment of response to imatinib therapy in patients with chronic myeloid leukemia with e13a2 and e14a2 transcripts of BCR/ABL1 gene.

6 A visual system model and a new distortion measure in the context of image processing.

7 Drug distribution in hospitals. Unit-dose systems reduce error, increase efficeincy.

8 Ethnic Differences in Hematologic Toxicity from Imatinib in Patients with Gastrointestinal Stromal Cell Tumor (GIST): Coincidence or a Real Phenomenon.

9 sustained response of a clivus chordoma to erlotinib after imatinib failure

10 a rare presentation of chronic myeloid leukemia blast crisis

11 treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice

12 frequency of the bcr/abl rearrangements and associated alterations detected by fish during monitoring of patients taking imatinib mesylate in isolation freqüência do rearranjo bcr/abl e alterações associadas detectadas por fish no monitoramento de pacientes em uso exclusivo do mesilato de imatinibe

13 imatinib treatment reduces brain injury in a murine model of traumatic brain injury

14 tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in cml patients

15 advances and challenges on management of gastrointestinal stromal tumors

16 Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation.

17 The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.

18 CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.